CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 217 SEK 1.17% Market Closed
Market Cap: 5.2B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CellaVision AB
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Total Current Liabilities
kr129.4m
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
11%
Elekta AB (publ)
STO:EKTA B
Total Current Liabilities
kr14B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Total Current Liabilities
kr243.8m
CAGR 3-Years
3%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Total Current Liabilities
kr13.2B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Total Current Liabilities
kr4.4B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Total Current Liabilities
kr181m
CAGR 3-Years
36%
CAGR 5-Years
43%
CAGR 10-Years
28%
No Stocks Found

CellaVision AB
Glance View

Market Cap
5.2B SEK
Industry
Health Care

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CEVI Intrinsic Value
265.65 SEK
Undervaluation 18%
Intrinsic Value
Price

See Also

What is CellaVision AB's Total Current Liabilities?
Total Current Liabilities
129.4m SEK

Based on the financial report for Sep 30, 2024, CellaVision AB's Total Current Liabilities amounts to 129.4m SEK.

What is CellaVision AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
11%

Over the last year, the Total Current Liabilities growth was 7%. The average annual Total Current Liabilities growth rates for CellaVision AB have been 2% over the past three years , 11% over the past five years , and 11% over the past ten years .

Back to Top